论文部分内容阅读
该文探讨高同型半胱氨酸(hyperhomocysteine,H-Hcy)水平对冠状动脉粥样硬化性心脏病(冠心病)患者冠状动脉病变严重程度及支架置入治疗远期预后的影响。方法:采取前瞻性研究方法,连续入选2011年3月至2013年1月在中大医院心内科首次接受冠状动脉内药物洗脱支架置入术治疗的冠心病患者1408例。根据是否合并H-Hcy分为两组,合并H-Hcy组798例(Hcy≥10μmol/L,占56.7%)、未合并
This study was designed to investigate the effect of hyperhomocysteine (H-Hcy) on the severity of coronary lesions and the long-term prognosis of patients with coronary atherosclerotic heart disease (CHD). Methods: A prospective study was conducted to select 1,408 CHD patients who underwent coronary stenting for coronary stent implantation in Department of Cardiology, CUHK from March 2011 to January 2013. According to whether H-Hcy was merged into two groups, there were 798 H-Hcy patients (Hcy≥10μmol / L, accounting for 56.7%) without merging